A Phase 2 Randomized Double-Blind Study of Relatlimab plus Nivolumab in Combination with Chemotherapy vs Nivolumab in Combination with Chemotherapy as First Line Treatment For Participants with Stage IV or Recurrent Non-Small Cell Lung Cancer
Condition: | Last Updated: 4 Apr 21 | Status: enrolling
View Full Study
